Cargando…

The first EGF domain of coagulation factor IX attenuates cell adhesion and induces apoptosis

Coagulation factor IX (FIX) is an essential plasma protein for blood coagulation. The first epidermal growth factor (EGF) motif of FIX (EGF-F9) has been reported to attenuate cell adhesion to the extracellular matrix (ECM). The purpose of the present study was to determine the effects of this motif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Tomomi, Kitano, Hisataka, Mamiya, Atsushi, Kokubun, Shinichiro, Hidai, Chiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2016
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293593/ https://www.ncbi.nlm.nih.gov/pubmed/27129300 http://dx.doi.org/10.1042/BSR20160098

Ejemplares similares

Long-term gene therapy with Del1 fragment using nonviral vectors in mice with explanted tumors
por: Kitano, Hisataka, et al.
Publicado: (2016)

The Del1 deposition domain can immobilize 3α-hydroxysteroid dehydrogenase in the extracellular matrix without interfering with enzymatic activity
por: Hidai, Chiaki, et al.
Publicado: (2008)

EGF domain peptide of Developmentally regulated endothelial locus1 facilitates gene expression of extracellularly applied plasmid DNA
por: Kitano, Hisataka, et al.
Publicado: (2022)

Nonviral Gene Therapy for Cancer: A Review
por: Hidai, Chiaki, et al.
Publicado: (2018)

Differences in the stemness characteristics and molecular markers of distinct human oral tissue neural crest‐derived multilineage cells
por: Abe, Shigehiro, et al.
Publicado: (2022)

Coagulation Factor IX for Hemophilia B Therapy 
por: Orlova, N. A., et al.
Publicado: (2012)

Probing activation‐driven changes in coagulation factor IX by mass spectrometry
por: Freato, Nadia, et al.
Publicado: (2021)

Caspase-8 Regulates Endoplasmic Reticulum Stress-Induced Necroptosis Independent of the Apoptosis Pathway in Auditory Cells
por: Kishino, Akihiro, et al.
Publicado: (2019)

Comparative domain modeling of human EGF-like module EMR2 and study of interaction of the fourth domain of EGF with chondroitin 4-sulphate()
por: Rani, Mukta, et al.
Publicado: (2011)

Ribosome profiling of HEK293T cells overexpressing codon optimized coagulation factor IX
por: Alexaki, Aikaterini, et al.
Publicado: (2020)

Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
por: Kenet, Gili, et al.
Publicado: (2016)

Roles of Specific Membrane Lipid Domains in EGF Receptor Activation and Cell Adhesion Molecule Stabilization in a Developing Olfactory System
por: Gibson, Nicholas J., et al.
Publicado: (2009)

Recombinant biosynthesis of functional human growth hormone and coagulation factor IX in transgenic soybean seeds
por: da Cunha, Nicolau Brito, et al.
Publicado: (2014)

Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies
por: Alexaki, Aikaterini, et al.
Publicado: (2019)

Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product
por: Zacchi, Lucia F., et al.
Publicado: (2021)

Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity
por: Lombardi, Silvia, et al.
Publicado: (2021)

Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023)

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023)

Dual roles of AMAP1 in the transcriptional regulation and intracellular trafficking of carbonic anhydrase IX
por: Horikawa, Mei, et al.
Publicado: (2021)

P130Cas Attenuates Epidermal Growth Factor (EGF) Receptor Internalization by Modulating EGF-Triggered Dynamin Phosphorylation
por: Kang, Yong Seok, et al.
Publicado: (2011)

Contribution of the CR Domain to P-Selectin Lectin Domain Allostery by Regulating the Orientation of the EGF Domain
por: Lü, Shouqin, et al.
Publicado: (2015)

Inhibition of the EGF Receptor by Binding to an Activating Kinase Domain Interface
por: Zhang, Xuewu, et al.
Publicado: (2007)

Small GTP‐binding protein Rap1 mediates EGF and HB‐EGF signaling and modulates EGF receptor expression in HTR‐8/SVneo extravillous trophoblast cells
por: Yoshie, Mikihiro, et al.
Publicado: (2023)

(1)H, (13)C and (15)N resonance assignments for the fibrillin-1 EGF2-EGF3-hybrid1-cbEGF1 four-domain fragment
por: Robertson, Ian B., et al.
Publicado: (2013)

Targeting of the Human Coagulation Factor IX Gene at rDNA Locus of Human Embryonic Stem Cells
por: Liu, Xionghao, et al.
Publicado: (2012)

Development of Methods for the Selective Measurement of the Single Amino Acid Exchange Variant Coagulation Factor IX Padua
por: Weber, Alfred, et al.
Publicado: (2018)

Maturation of coagulation factor IX during Xase formation as deduced using factor VIII‐derived peptides
por: Fang, Han, et al.
Publicado: (2019)

Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity
por: Zhao, Ying, et al.
Publicado: (2017)

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa
por: Nichols, Timothy C., et al.
Publicado: (2020)

A negative feedback loop attenuates EGF-induced morphological changes
Publicado: (1991)

Localization of the Adhesion Receptor Glycoprotein Ib-IX-V Complex to Lipid Rafts Is Required for Platelet Adhesion and Activation
por: Shrimpton, Corie N., et al.
Publicado: (2002)

Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved.
por: Purushotham, A. D., et al.
Publicado: (1991)

Acquired Inhibitors to Multiple Coagulation Factors (V, IX, and XII) Identified in a Unique Patient with Hepatocellular Carcinoma
por: Imataki, Osamu, et al.
Publicado: (2017)

Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria
por: Chen, Jinwu, et al.
Publicado: (2019)

Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease)
por: Larson, Emily A., et al.
Publicado: (2021)

Differences in adhesion and protrusion properties correlate with differences in migration speed under EGF stimulation
por: Hou, Yue, et al.
Publicado: (2012)

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy
por: Tagliaferri, Annarita, et al.
Publicado: (2022)

Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling
por: Müller, Elisabeth, et al.
Publicado: (2014)

Compensated pathogenic variants in coagulation factors VIII and IX present complex mapping between molecular impact and hemophilia severity
por: Marín, Òscar, et al.
Publicado: (2019)

Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one‐stage clotting assays
por: Horn, C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s2i9fojb81en1na505ejquctdk